Nektar Therapeutics
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Nektar Therapeutics
... The latest update for Nektar's immuno-oncology asset NKTR-214 given in combination with Bristol-Myers Squibb's Opdivo showed a ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that new clinical and preclinical data will be ...
... Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the first quarter ended ...
Subscribe now for full coverage on Nektar Therapeutics
Start My Free Trial